X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Find a Clinical Trial

Clinical trials have helped hundreds of thousands of people – who are alive today – because new, more effective treatments became available. It’s important to take charge of your health and educate yourself about clinical trials you are eligible for based on your current situation.

Get matched to a prostate cancer clinical trial that’s right for you! Print out your results to discuss with your treatment team, or contact the study coordinators directly.

Featured Clinical Trials

Below are featured clinical trials you may be interested in learning more about. Be sure to use ZERO’s clinical trial finder above or visit www.clinicaltrials.gov to learn about all prostate cancer clinical trials you may be eligible for. You can use the results of these clinical trial finder tools to have conversations with your doctor.

  • Now enrolling – the SPLASH clinical trial is evaluating if [Lu-177]-PNT2002, a radioligand therapy (RLT), can effectively slow down the progression of metastatic Castration-Resistant Prostate Cancer (mCRPC).  The study is looking  for mCRPC patients who have progressed following treatment with androgen receptor axis-targeted therapy (ARAT) and are either ineligible or are electing not to receive treatment with chemotherapy. More information about participation is available on the study website. Find Out More!
  • If you are experiencing symptoms of anxiety and stress-related to cancer, you may qualify for Blue Note’s Restore Study. By joining this study, you will get access to a mobile-app-based investigative digital therapy over 12 weeks intended to manage cancer-related anxiety and stress symptoms. Earn up to $200 for participating. You might qualify if you have a stage I, II, or III cancer diagnosis, you have undergone treatment sometime in the last 6 months, or have planned future treatment, and/or, you are experiencing cancer-related anxiety and/or stress symptoms. Find out if you’re eligible by taking this survey!

 

Click HERE to learn more about clinical trial phases, eligibility, informed consent, and patient protection.